OBALIX 20 mg COMPRIMIDOS
OBALIX 20 mg COMPRIMIDOS
Pending
Register Number
73028
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Nov 17, 2010
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number73028
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
BILASTINAActive
Quantity: 20 mg
Name: BILASTINA
ATC CLASSIFICATION (3)
R06A
R06AX
R06AX29